Hemostemix Inc (TSE:HEM)
TSXV:HEM

Hemostemix (HEM) Financial Statements

13 Followers

Hemostemix Financial Overview

Hemostemix's market cap is currently ―. The company's EPS TTM is C$-0.02; its P/E ratio is -2.12; Hemostemix is scheduled to report earnings on August 26, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ -329.98KC$ -455.16KC$ -142.02KC$ -173.89KC$ -1.17M
EBITDAC$ -329.95KC$ -455.11KC$ -141.97KC$ -173.83KC$ -1.17M
Net Income Common StockholdersC$ -475.53KC$ -683.59KC$ -257.24KC$ -284.94KC$ -1.28M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 35.07KC$ 155.42KC$ 377.59KC$ 154.32KC$ 272.34K
Total AssetsC$ 94.36KC$ 313.76KC$ 701.15KC$ 305.11KC$ 500.71K
Total DebtC$ 4.47MC$ 4.32MC$ 4.29MC$ 4.19MC$ 4.02M
Net DebtC$ 4.43MC$ 4.17MC$ 3.91MC$ 4.03MC$ 3.75M
Total LiabilitiesC$ 7.94MC$ 7.68MC$ 7.55MC$ 7.19MC$ 7.48M
Stockholders EquityC$ -7.84MC$ -7.37MC$ -6.85MC$ -6.88MC$ -6.98M
Cash Flow-
Free Cash FlowC$ -120.35KC$ -240.49KC$ -66.14KC$ -401.75KC$ -711.38K
Operating Cash FlowC$ -120.35KC$ -240.49KC$ -66.14KC$ -401.75KC$ -711.38K
Investing Cash Flow-----
Financing Cash Flow-C$ 18.31KC$ 289.41KC$ 283.74KC$ 847.97K
Currency in CAD

Hemostemix Earnings and Revenue History

Hemostemix Debt to Assets

Hemostemix Cash Flow

Hemostemix Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis